Clinical Trial Update: Abatacept in earLy Onset Polymyalgia Rheumatica: Study ALORS [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update for abatacept in early-onset polymyalgia rheumatica (ALORS) is reported with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polymyalgia Rheumatica

Drugs mentioned

• Abatacept (abatacept)

Snippet

Sponsor: University Hospital, Brest | Conditions: Polymyalgia Rheumatica | Phase 3 | Status: UNKNOWN